PharmaMar and Jazz Announce FDA Acceptance and Priority Review of New Drug Application for…
PharmaMar and Jazz Pharmaceuticals plc announce that the U.S. Food and Drug Administration (FDA) accepted for filing with Priority Review the New Drug Application (NDA) seeking…
Read More...
Read More...
